Merck (MRK) PT Raised to $84 at BMO Capital
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $148.78 +0.54%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
BMO Capital analyst Alex Arfaei raised the price target on Merck (NYSE: MRK) to $84.00 (from $83.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR1,875 at Citi
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR140 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
